Mats Karlsson
Mats Karlsson
Verified email at
Cited by
Cited by
Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
EN Jonsson, MO Karlsson
Computer methods and programs in biomedicine 58 (1), 51-64, 1998
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models
M Bergstrand, AC Hooker, JE Wallin, MO Karlsson
The AAPS journal 13 (2), 143-151, 2011
The importance of modeling interoccasion variability in population pharmacokinetic analyses
MO Karlsson, LB Sheiner
Journal of pharmacokinetics and biopharmaceutics 21 (6), 735-750, 1993
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs
LE Friberg, A Henningsson, H Maas, L Nguyen, MO Karlsson
Journal of clinical oncology 20 (24), 4713-4721, 2002
Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions
RM Savic, MO Karlsson
The AAPS journal 11 (3), 558-569, 2009
Diagnosing model diagnostics
MO Karlsson, RM Savic
Clinical Pharmacology & Therapeutics 82 (1), 17-20, 2007
Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose
RJ Keizer, MO Karlsson, A Hooker
CPT: pharmacometrics & systems pharmacology 2 (6), 1-9, 2013
Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
RM Savic, DM Jonker, T Kerbusch, MO Karlsson
Journal of pharmacokinetics and pharmacodynamics 34 (5), 711-726, 2007
Pharmacokinetics and safety of intravenous voriconazole in children after single-or multiple-dose administration
TJ Walsh, MO Karlsson, T Driscoll, AG Arguedas, P Adamson, ...
Antimicrobial agents and chemotherapy 48 (6), 2166-2172, 2004
The axial double probe and fields signal processing for the MMS mission
RE Ergun, S Tucker, J Westfall, KA Goodrich, DM Malaspina, D Summers, ...
Space Science Reviews 199 (1-4), 167-188, 2016
Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method
AC Hooker, CE Staatz, MO Karlsson
Pharmaceutical research 24 (12), 2187-2197, 2007
Assessment of actual significance levels for covariate effects in NONMEM
U Wählby, EN Jonsson, MO Karlsson
Journal of pharmacokinetics and pharmacodynamics 28 (3), 231-252, 2001
Irinotecan pathway genotype analysis to predict pharmacokinetics
RHJ Mathijssen, S Marsh, MO Karlsson, R Xie, SD Baker, J Verweij, ...
Clinical cancer research 9 (9), 3246-3253, 2003
The FIELDS instrument suite for solar probe plus
SD Bale, K Goetz, PR Harvey, P Turin, JW Bonnell, TD De Wit, RE Ergun, ...
Space science reviews 204 (1), 49-82, 2016
Likelihood based approaches to handling data below the quantification limit using NONMEM VI
JE Ahn, MO Karlsson, A Dunne, TM Ludden
Journal of pharmacokinetics and pharmacodynamics 35 (4), 401-421, 2008
Automated covariate model building within NONMEM
EN Jonsson, MO Karlsson
Pharmaceutical research 15 (9), 1463-1468, 1998
Handling data below the limit of quantification in mixed effect models
M Bergstrand, MO Karlsson
The AAPS journal 11 (2), 371-380, 2009
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
A Henningsson, S Marsh, WJ Loos, MO Karlsson, A Garsa, K Mross, ...
Clinical Cancer Research 11 (22), 8097-8104, 2005
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies
MO Karlsson, I Lutsar, PA Milligan
Antimicrobial agents and chemotherapy 53 (3), 935-944, 2009
Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis
U Wählby, EN Jonsson, MO Karlsson
Aaps Pharmsci 4 (4), 68-79, 2002
The system can't perform the operation now. Try again later.
Articles 1–20